Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio Shareholders Equity (Quarterly) : 227.98M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 227.98M |
| June 30, 2026 | 253.86M |
| March 31, 2026 | 319.56M |
| December 31, 2025 | 305.72M |
| September 30, 2025 | 325.88M |
| June 30, 2025 | 372.91M |
| March 31, 2025 | 419.46M |
| December 31, 2024 | 463.79M |
| September 30, 2024 | 502.71M |
| June 30, 2024 | 257.19M |
| March 31, 2024 | 594.04M |
| December 31, 2023 | 605.12M |
| September 30, 2023 | 611.59M |
| Date | Value |
|---|---|
| June 30, 2023 | 624.63M |
| March 31, 2023 | 641.07M |
| December 31, 2022 | 655.08M |
| September 30, 2022 | 667.94M |
| June 30, 2022 | 693.08M |
| March 31, 2022 | 723.56M |
| December 31, 2021 | 746.00M |
| September 30, 2021 | 769.37M |
| June 30, 2021 | 788.94M |
| March 31, 2021 | 806.34M |
| December 31, 2020 | 215.08M |
| September 30, 2020 | 144.52M |
| June 30, 2020 | 0.024M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 89.00B |
| Johnson & Johnson | 81.53B |
| Merck & Co., Inc. | 44.89B |
| Bristol Myers Squibb Co. | 23.40B |
| ANI Pharmaceuticals, Inc. | 637.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 778.39M |
| Total Liabilities (Quarterly) | 550.42M |
| Debt to Equity Ratio | 2.053 |
| Current Ratio | 7.454 |
| Net Debt Paydown Yield | -2.68% |